# Rhythm (RYTM) — Overview

RYTM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rytm

## Price

Last close $87.97 on Oct 15, 2026. 52-week range $75.82 – $117.62.

## Company profile

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $239.9M |
| Revenue (quarter) | $71.3M |
| Revenue growth (year over year) | 46.91% |
| Gross profit (trailing twelve months) | $213.5M |
| Gross margin | 89.00% |
| Net income (trailing twelve months) | −$205.3M |
| Net income (quarter) | −$49.3M |
| Net income growth (year over year) | -5.72% |
| Net margin | -85.59% |
| Return on equity | -204.70% |
| EPS (trailing twelve months) | −$3.12 |
| Book value per share | $3.16 |
| P/E (trailing twelve months) | — |
| Price to book | 27.9 |
| Debt to assets | 50.30% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Rhythm (RYTM) profitable?

No. Rhythm reported a net loss of $205.3M over the trailing twelve months.

### How much revenue does Rhythm (RYTM) make?

Rhythm generated $239.9M in revenue over the trailing twelve months, up 46.91% year over year.

### How do I buy stock in Rhythm (RYTM)?

RYTM trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).